|
|
|
|
| Symbol(s): |
MDCO |
| Date: |
7-Feb-10 |
| Contributor: |
PriceTarget Research, Inc. |
| Title: |
Medicines has a current Overall Rating of D (Negative). |
| Document Size: |
7 pages |
| Price: |
$25 |
| Document Type: |
Adobe Acrobat Reader®
Download free Adobe Acrobat Reader® |
|
| Research Reports Premium Services |
| ·
|
Get the full report for $25. |
| ·
|
You will have access to this report for 24 hours. |
|
|
|
|
|
| Medicines has a current Overall Rating of D (Negative). Power Rating (24) is low; appreciation potential (24) is negative. Relative to the S&P 500 Composite, Medicines Company has slightly more Value than Growth characteristics -- its appeal is likely to be to Capital Gain-oriented investors. MDCO is of high investment quality. Current annual total return performance of -11.5% is lower quartile. Over the full time period, Medicines' stock price performance has been variable and superior....
| | |
|
|
